Effect of short-term intravenous ascorbic acid on reducing ferritin in hemodialysis patients
{{output}}
Resistance to recombinant erythropoietin (rEPO) in hemodialysis patients may be due to inadequate iron recruitment and defect in iron use. In this cross over randomized clinical trial, 30 hemodialysis patients with serum ferritin levels of ≥500 ng/ml, hemoglo... ...
